(SMMT) Summit Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Summit Therapeutics | (SMMT) share price targets
Complete technical analysis of Summit Therapeutics (SMMT) by charts plus indicators, forecast predictions and share price targets for Summit Therapeutics (SMMT)
Summit Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-06-03 View latest technical analysis
10 day averaged volume of Summit Therapeutics is 5289410
Date | Daily Closing Price | Open | High | Low | Volume |
03 Tue Jun 2025 | 20.62 | 18.40 | 20.67 | 17.32 | 2.31 times |
02 Mon Jun 2025 | 17.73 | 18.81 | 18.81 | 16.03 | 2.673 times |
30 Fri May 2025 | 18.22 | 21.20 | 21.63 | 18.01 | 3.754 times |
29 Thu May 2025 | 26.21 | 26.38 | 27.09 | 26.03 | 0.405 times |
28 Wed May 2025 | 26.04 | 25.66 | 26.35 | 25.07 | 0.377 times |
27 Tue May 2025 | 25.64 | 26.29 | 26.90 | 25.54 | 0.42 times |
23 Fri May 2025 | 25.85 | 25.48 | 26.17 | 25.12 | 0.333 times |
22 Thu May 2025 | 25.77 | 25.62 | 26.44 | 25.05 | 0.555 times |
21 Wed May 2025 | 25.41 | 24.13 | 26.85 | 23.88 | 0.834 times |
20 Tue May 2025 | 24.39 | 23.64 | 24.45 | 23.45 | 0.348 times |
Stock of Summit Therapeutics (SMMT) has showed a significant upmove. This could be a good time to enter in this stock!
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 21.5, but if it comes above 21.5, then a intra day buy could be more profitable.
If you take a sell trade below 21.5, then use 21.5 as stoploss and 18.7 as target. However if you take a buy trade in stock , then use 21.5 as stoploss and 23.83 as target.
Share price targets for Summit Therapeutics (SMMT)
Target Type | Value |
Downside Target | 15.55 |
Downside Target | 16.03 |
Downside Target | 16.55 |
Downside Target | 17.70 |
Upside Target | 20.67 |
Upside Target | 21.38 |
Upside Target | 22.85 |
Upside Target | 23.45 |
Upside Target | 24.18 |
Upside Target | 25.50 |
Upside Target | 26.85 |
Upside Target | 27.09 |
Upside Target | 28.28 |
Upside Target | 29.99 |
Upside Target | 36.91 |
Intraday share price targets for Summit Therapeutics (SMMT)
Target Type | Value |
Downside Intraday Target | 17.54 |
Downside Intraday Target | 14.47 |
Upside Intraday Target | 22.18 |
Upside Intraday Target | 23.75 |
Downside Intraday Target | 19.11 |
Weekly technical analysis of Summit Therapeutics (SMMT)
Date | Weekly Closing Price | Open | High | Low | Volume |
03 Tue Jun 2025 | 20.62 | 18.81 | 20.67 | 16.03 | 1.005 times |
30 Fri May 2025 | 18.22 | 26.29 | 27.09 | 18.01 | 2.09 times |
23 Fri May 2025 | 25.85 | 23.80 | 26.85 | 22.85 | 0.937 times |
16 Fri May 2025 | 23.87 | 23.26 | 25.50 | 21.75 | 0.846 times |
09 Fri May 2025 | 23.96 | 27.90 | 28.28 | 23.45 | 0.485 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Summit Therapeutics (SMMT)
Date | Monthly Closing Price | Open | High | Low | Volume |
03 Tue Jun 2025 | 20.62 | 18.81 | 20.67 | 16.03 | 0.334 times |
30 Fri May 2025 | 18.22 | 24.38 | 29.99 | 18.01 | 0.635 times |
30 Wed Apr 2025 | 24.12 | 19.19 | 36.91 | 15.55 | 2.889 times |
31 Mon Mar 2025 | 19.29 | 20.80 | 21.38 | 16.55 | 0.9 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Summit Therapeutics (SMMT)
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term and the sell signal is strong.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Summit Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Summit Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.59 and Summit Therapeutics (SMMT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term and the sell signal is strong.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Summit Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Summit Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.59 and Summit Therapeutics (SMMT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.